Celldex Q4 revenue falls
Overview
Biotech firm's Q4 revenue fell yr/yr
Net loss for Q4 exceeded analyst estimates
Outlook
Celldex anticipates topline data from Phase 3 CSU studies in Q4 2026
Company expects Phase 2 prurigo nodularis data in summer 2026
Result Drivers
R&D Expenses - Research and development expenses were $75.3 million in the fourth quarter of 2025
Company press release: ID:nGNX46ZlBw
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $121,000 |
|
Q4 EPS | Miss | -$1.22 | -$1.009 (14 Analysts) |
Q4 Net Income |
| -$81.32 mln | -$68.13 mln (9 Analysts) |
Q4 Operating Expenses |
| $87.27 mln |
|
Q4 Operating Income |
| -$87.15 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 2 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the biotechnology & medical research peer group is "buy"
Wall Street's median 12-month price target for Celldex Therapeutics Inc is $48.00, about 93.2% above its February 24 closing price of $24.84
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
Related Articles
Circle Stock Price Outlook: Will Circle Internet Group Rebound in 2026?
TradingKey - Circle Internet Group (CRCL) saw its stock price experience a roller coaster ride since its 2025 IPO debut at $31 a share. Those early fireworks faded, and the shares now sit roughly 75% below their June peak, though they’re still more than double the IPO level. Outside of that first-mo
Paramount Offers High Price Again to Bid for Warner Bros., Netflix Acquisition Hits Twists and Turns.
TradingKey - Hollywood media group Warner Bros. (WBD) announced Tuesday that it has received a revised acquisition proposal from Paramount (PSKY), raising the offer from the previous $30 to $31 per share in cash. The Board of Directors stated that this new bid "is likely to constitute a superior proposal" to the current agreement with Netflix and noted that negotiations between the two parties are continuing. The existing deal with Netflix (NFLX) remains in effect, as the Warner Bros. Board has not yet formally designated the Paramount offer as the superior proposal.
Nvidia Q4 Earnings: Market Fears Competition, but NVDA Moat is Beyond CUDA
All eyes are on Nvidia this week, as the company reports its 2026Q4 earnings.
Nvidia Q4 Earnings Preview: AI-Driven Growth Versus Market Expectations
TradingKey - NVIDIA (NVDA) is set to release its fourth quarter fiscal year 2026 earnings report after the market close on February 25, ET. As the world undergoes a period of rapid AI technological advancement, market debates over a capital expenditure bubble have intensified. In this context, NVIDIA’s results serve not only as a test of its business performance but also as a core bellwether for the sustainability of the global AI boom.
